{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:13:49Z","timestamp":1774934029926,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bioorg.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T12:10:20Z","timestamp":1534421420000},"page":"241-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX"],"prefix":"10.1016","volume":"81","author":[{"given":"Peter","family":"Miku\u0161","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Kraj\u010diov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1ria","family":"Mikulov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branislav","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-1493","authenticated-orcid":false,"given":"Daniel","family":"Pecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Garaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.08.005_b0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Thiry","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2018.08.005_b0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5306\/wjco.v3.i7.98","article-title":"Inhibition of carbonic anhydrase IX as a novel anticancer mechanism","volume":"3","author":"Supuran","year":"2012","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2018.08.005_b0015","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2018.08.005_b0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/1078-0432.97.11.1","article-title":"Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma","volume":"11","author":"Hoogsteen","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2018.08.005_b0025","first-page":"7992","article-title":"Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer","volume":"61","author":"Giatromanolaki","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2018.08.005_b0030","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","article-title":"Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma","volume":"19","author":"Chia","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2018.08.005_b0035","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ijc.22436","article-title":"HIF-1\u03b1 and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome","volume":"120","author":"Trastour","year":"2007","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.bioorg.2018.08.005_b0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/1078-0432.CCR-05-0848","article-title":"Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis","volume":"12","author":"Haapasalo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2018.08.005_b0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3748\/wjg.v11.i2.155","article-title":"Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours","volume":"11","author":"Kivel\u00e4","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2018.08.005_b0050","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.3748\/wjg.v22.i36.8168","article-title":"Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas","volume":"22","author":"Viikil\u00e4","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2018.08.005_b0055","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.ejca.2005.09.011","article-title":"The role of carbonic anhydrase IX overexpression in kidney cancer","volume":"41","author":"Dorai","year":"2005","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.bioorg.2018.08.005_b0060","first-page":"6394","article-title":"Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix","volume":"61","author":"Loncaster","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2018.08.005_b0065","first-page":"5666","article-title":"Carbonic Anhydrase IX Expression, Hypoxia, and Prognosis in Patients with Uterine Cervical Carcinomas","volume":"9","author":"Hedley","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2018.08.005_b0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2018.08.005_b0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.bioorg.2018.08.005_b0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2407-10-148","article-title":"The tumour-associated carbonic anhydrases CA II CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis","volume":"10","author":"Nordfors","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2018.08.005_b0085","unstructured":"National Center for Biotechnology Information, NCBI report for CA1 carbonic anhydrase 1. https:\/\/www.ncbi.nlm.nih.gov\/gene\/759, 2018 (updated 7 Jan 2018)."},{"key":"10.1016\/j.bioorg.2018.08.005_b0090","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0016-5085(93)90900-W","article-title":"The significance of carbonic anhydrase expression in human colorectal cancer","volume":"105","author":"Mori","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioorg.2018.08.005_b0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bmc.2016.11.027","article-title":"Discovery of 4-sulfamoyl-phenyl-\u03b2-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors The first example of subnanomolar CA IV inhibitors","volume":"25","author":"Angapelly","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0100","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bmcl.2003.12.029","article-title":"Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX","volume":"14","author":"Pastorekova","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.08.005_b0105","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors","volume":"48","author":"Cecchi","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0110","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1021\/jm060967z","article-title":"A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by \u201cclick-tailing\u201d","volume":"49","author":"Wilkinson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0115","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0120","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.08.005_b0125","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.08.005_b0130","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.08.005_b0135","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","article-title":"Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies","volume":"19","author":"Carta","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0140","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bmcl.2014.01.048","article-title":"Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII","volume":"24","author":"Saluja","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.08.005_b0145","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.bmc.2013.09.031","article-title":"Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties","volume":"21","author":"Ceruso","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bioorg.2017.12.034","article-title":"Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action","volume":"77","author":"Havr\u00e1nkov\u00e1","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/metabo8020036","article-title":"Amino acids as building blocks for carbonic anhydrase inhibitors","volume":"8","author":"Chiaramonte","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2018.08.005_b0160","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3390\/molecules22091533","article-title":"Optimization and Comparison of Synthetic Procedures for a Group of Triazinyl-Substituted Benzene-Sulfonamide Conjugates with Amino Acids","volume":"22","author":"Kraj\u010diov\u00e1","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2018.08.005_b0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1021\/jo01087a018","article-title":"Preparation of Some Sulfanilamide Derivatives of s-Triazine","volume":"24","author":"D\u2019Alelio","year":"1959","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0170","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0175","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1016\/j.bmcl.2012.07.094","article-title":"Inhibition of \u03b1-class cytosolic human carbonic anhydrases I, II, IX and XII, and \u03b2-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors","volume":"22","author":"Sechi","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.08.005_b0180","unstructured":"P. Miku\u0161, et al., Metal complexes of triazinyl-substituted aminoalkylbenzenesulfonamides conjugated with chelating moieties as a new class of potential (radio)pharmaceuticals (in preparation)."},{"key":"10.1016\/j.bioorg.2018.08.005_b0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","article-title":"Dithiocarbamates strongly inhibit the \u03b2- class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0190","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/14756366.2011.621122","article-title":"Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds","volume":"27","author":"Ekinci","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14756366.2011.643303","article-title":"Carbonic anhydrase inhibitors: in vitro inhibition of \u03b1 isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids","volume":"28","author":"Ekinci","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/14756366.2012.658788","article-title":"Secondary\/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II","volume":"28","author":"Alp","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.005_b0205","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2018.08.005_b0210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aid. Mol. Des."},{"key":"10.1016\/j.bioorg.2018.08.005_b0215","unstructured":"LigPrep, version 3.5, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2018.08.005_b0220","unstructured":"Epik, version 3.3, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2018.08.005_b0225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKa prediction and protonation state generation for druglike molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2018.08.005_b0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2018.08.005_b0235","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/0005-2795(70)90020-6","article-title":"Sulphonamide complexes of human carbonic anhydrases ultraviolet difference spectroscopy","volume":"207","author":"King","year":"1970","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2018.08.005_b0240","unstructured":"Glide, version 6.8, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2018.08.005_b0245","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818306412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818306412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T12:31:04Z","timestamp":1661776264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818306412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":49,"alternative-id":["S0045206818306412"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.08.005","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}